Horse /

Breed profile · FDA CVM July 2026 extract

Shetland Pony adverse-event record

Adverse-event filings for Shetland Pony (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

#316 of 510
by report volume (all breeds)
33
FDA CVM reports on file
21.2%
death-coded share of reports
3
Diarrhoea - top reaction

How the 33 reports break down

By recorded gender -- every report on file for Shetland Pony, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 3 2.25 1.5 0.75 0 2017 2019 2020 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Shetland Pony drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Shetland Pony ranks #310 of 510 by total reports (33). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#310
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Shetland Pony has 33 reports now versus 29 in that prior snapshot: 4 more (13.8%).

Report change
+4
Death-coded reports
+0
Death-coded share
−2.9 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Shetland Pony changes

Total Reports

33

Below-median volume

Deaths Reported

7

of 33 reports

Death-coded share of reports

21.2%

21.2% death-coded

Avg Age at Report

17.7 yr

179.0 kg avg weight

Death-Coded Outcome Share

Shetland Pony death-coded reports 21.2%
Cross-breed median

21.2% of 33 shetland pony reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 179.0 kg (394.7 lbs)

Top Reported Reactions

Diarrhoea 3
Accidental exposure 3
Blindness 3
Death by euthanasia 3
Anorexia 3

Most Referenced Drugs

Pergolide Mesylate 7
Firocoxib 6
Velagliflozin Proline Monohydrate 5
Detomidine Hydrochloride 3
Ceftiofur Crystalline Free Acid 3

Outcome Breakdown

Outcome Unknown
11 (37.9%)
Recovered/Normal
8 (27.6%)
Died
6 (20.7%)
Ongoing
3 (10.3%)
Euthanized
1 (3.4%)

Gender Distribution

Male 17 (51.5%)
Female 15 (45.5%)
Mixed 1 (3.0%)

Reports by Year

Year Reports Trend
2010 3
2011 4
2012 1
2013 1
2014 5
2015 1
2016 1
2017 2
2019 2
2020 1
2022 2
2023 2
2024 3
2025 2
2026 3

Shetland Pony: high death-coded share in the FDA CVM extract

Signature read: Shetland Pony's 21.2% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Shetland Pony sits at #316 of 510 by report volume among all breeds and #30 of 55 among horse breeds, with 33 reports and 7 (21.2%) death-coded. Mean age at report: 17.7 years, average weight 179.0 kg (394.7 lbs).

Top reported signs: Diarrhoea (3), Accidental exposure (3), Blindness (3). Most-referenced drug: Pergolide Mesylate (7 reports), followed by Firocoxib (6) and Velagliflozin Proline Monohydrate (5).

Outcome coding on 29 status-recorded reports is dominated by Outcome Unknown (37.9%). Annual submissions ranged 1-2,026 across 15 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Shetland Pony, both outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Shetland Pony?
There are 33 adverse event reports involving Shetland Pony in the FDA database, of which 7 were death-coded (21.2% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Shetland Pony ranks #316 of 510 by report volume among all breeds PlainBreed indexes (#30 of 55 among horse breeds).
Where does Shetland Pony sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Shetland Pony is #316 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #30 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Shetland Pony?
The most commonly reported adverse reactions for Shetland Pony are Diarrhoea (3 reports), Accidental exposure (3 reports), Blindness (3 reports), Death by euthanasia (3 reports), Anorexia (3 reports).
What drugs are most frequently associated with Shetland Pony adverse events?
The drugs most frequently referenced in Shetland Pony adverse event reports are Pergolide Mesylate (7 reports), Firocoxib (6 reports), Velagliflozin Proline Monohydrate (5 reports), Detomidine Hydrochloride (3 reports), Ceftiofur Crystalline Free Acid (3 reports).
What is the average age of Shetland Pony in adverse event reports?
The average age of Shetland Pony at the time of adverse event reports is 17.7 years, with an average weight of 179.0 kg (394.7 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Shetland Pony (Horse), extract as of July 2026 extract. 33 reports · 7 death-coded (21.2% of reports, not a mortality rate) · #316 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →